ArticleCancers2021

Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment.

Yu-Li Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.